Utilizing a Human–Computer Interaction Approach to Evaluate the Design of Current Pharmacogenomics Clinical Decision Support

A formal assessment of pharmacogenomics clinical decision support (PGx-CDS) by providers is lacking in the literature. The objective of this study was to evaluate the usability of PGx-CDS tools that have been implemented in a healthcare setting. We enrolled ten prescribing healthcare providers and h...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Amanda L. Elchynski, Nina Desai, Danielle D’Silva, Bradley Hall, Yael Marks, Kristin Wiisanen, Emily J. Cicali, Larisa H. Cavallari, Khoa A. Nguyen
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	clinical decision support pharmacogenomics human–computer interaction usability evaluation formal assessment Medicine R
Acceso en línea:	https://doaj.org/article/96f17cbfed494c0bb338c2a177ab9b6f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:96f17cbfed494c0bb338c2a177ab9b6f
record_format	dspace
spelling	oai:doaj.org-article:96f17cbfed494c0bb338c2a177ab9b6f2021-11-25T18:08:09ZUtilizing a Human–Computer Interaction Approach to Evaluate the Design of Current Pharmacogenomics Clinical Decision Support10.3390/jpm111112272075-4426https://doaj.org/article/96f17cbfed494c0bb338c2a177ab9b6f2021-11-01T00:00:00Zhttps://www.mdpi.com/2075-4426/11/11/1227https://doaj.org/toc/2075-4426A formal assessment of pharmacogenomics clinical decision support (PGx-CDS) by providers is lacking in the literature. The objective of this study was to evaluate the usability of PGx-CDS tools that have been implemented in a healthcare setting. We enrolled ten prescribing healthcare providers and had them complete a 60-min usability session, which included interacting with two PGx-CDS scenarios using the “Think Aloud” technique, as well as completing the Computer System Usability Questionnaire (CSUQ). Providers reported positive comments, negative comments, and suggestions for the two PGx-CDS during the usability testing. Most provider comments were in favor of the current PGx-CDS design, with the exception of how the genotype and phenotype information is displayed. The mean CSUQ score for the PGx-CDS overall satisfaction was 6.3 ± 0.95, with seven strongly agreeing and one strongly disagreeing for overall satisfaction. The implemented PGx-CDS at our institution was well received by prescribing healthcare providers. The feedback collected from the session will guide future PGx-CDS designs for our healthcare system and provide a framework for other institutions implementing PGx-CDS.Amanda L. ElchynskiNina DesaiDanielle D’SilvaBradley HallYael MarksKristin WiisanenEmily J. CicaliLarisa H. CavallariKhoa A. NguyenMDPI AGarticleclinical decision supportpharmacogenomicshuman–computer interactionusability evaluationformal assessmentMedicineRENJournal of Personalized Medicine, Vol 11, Iss 1227, p 1227 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	clinical decision support pharmacogenomics human–computer interaction usability evaluation formal assessment Medicine R
spellingShingle	clinical decision support pharmacogenomics human–computer interaction usability evaluation formal assessment Medicine R Amanda L. Elchynski Nina Desai Danielle D’Silva Bradley Hall Yael Marks Kristin Wiisanen Emily J. Cicali Larisa H. Cavallari Khoa A. Nguyen Utilizing a Human–Computer Interaction Approach to Evaluate the Design of Current Pharmacogenomics Clinical Decision Support
description	A formal assessment of pharmacogenomics clinical decision support (PGx-CDS) by providers is lacking in the literature. The objective of this study was to evaluate the usability of PGx-CDS tools that have been implemented in a healthcare setting. We enrolled ten prescribing healthcare providers and had them complete a 60-min usability session, which included interacting with two PGx-CDS scenarios using the “Think Aloud” technique, as well as completing the Computer System Usability Questionnaire (CSUQ). Providers reported positive comments, negative comments, and suggestions for the two PGx-CDS during the usability testing. Most provider comments were in favor of the current PGx-CDS design, with the exception of how the genotype and phenotype information is displayed. The mean CSUQ score for the PGx-CDS overall satisfaction was 6.3 ± 0.95, with seven strongly agreeing and one strongly disagreeing for overall satisfaction. The implemented PGx-CDS at our institution was well received by prescribing healthcare providers. The feedback collected from the session will guide future PGx-CDS designs for our healthcare system and provide a framework for other institutions implementing PGx-CDS.
format	article
author	Amanda L. Elchynski Nina Desai Danielle D’Silva Bradley Hall Yael Marks Kristin Wiisanen Emily J. Cicali Larisa H. Cavallari Khoa A. Nguyen
author_facet	Amanda L. Elchynski Nina Desai Danielle D’Silva Bradley Hall Yael Marks Kristin Wiisanen Emily J. Cicali Larisa H. Cavallari Khoa A. Nguyen
author_sort	Amanda L. Elchynski
title	Utilizing a Human–Computer Interaction Approach to Evaluate the Design of Current Pharmacogenomics Clinical Decision Support
title_short	Utilizing a Human–Computer Interaction Approach to Evaluate the Design of Current Pharmacogenomics Clinical Decision Support
title_full	Utilizing a Human–Computer Interaction Approach to Evaluate the Design of Current Pharmacogenomics Clinical Decision Support
title_fullStr	Utilizing a Human–Computer Interaction Approach to Evaluate the Design of Current Pharmacogenomics Clinical Decision Support
title_full_unstemmed	Utilizing a Human–Computer Interaction Approach to Evaluate the Design of Current Pharmacogenomics Clinical Decision Support
title_sort	utilizing a human–computer interaction approach to evaluate the design of current pharmacogenomics clinical decision support
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/96f17cbfed494c0bb338c2a177ab9b6f
work_keys_str_mv	AT amandalelchynski utilizingahumancomputerinteractionapproachtoevaluatethedesignofcurrentpharmacogenomicsclinicaldecisionsupport AT ninadesai utilizingahumancomputerinteractionapproachtoevaluatethedesignofcurrentpharmacogenomicsclinicaldecisionsupport AT danielledsilva utilizingahumancomputerinteractionapproachtoevaluatethedesignofcurrentpharmacogenomicsclinicaldecisionsupport AT bradleyhall utilizingahumancomputerinteractionapproachtoevaluatethedesignofcurrentpharmacogenomicsclinicaldecisionsupport AT yaelmarks utilizingahumancomputerinteractionapproachtoevaluatethedesignofcurrentpharmacogenomicsclinicaldecisionsupport AT kristinwiisanen utilizingahumancomputerinteractionapproachtoevaluatethedesignofcurrentpharmacogenomicsclinicaldecisionsupport AT emilyjcicali utilizingahumancomputerinteractionapproachtoevaluatethedesignofcurrentpharmacogenomicsclinicaldecisionsupport AT larisahcavallari utilizingahumancomputerinteractionapproachtoevaluatethedesignofcurrentpharmacogenomicsclinicaldecisionsupport AT khoaanguyen utilizingahumancomputerinteractionapproachtoevaluatethedesignofcurrentpharmacogenomicsclinicaldecisionsupport
_version_	1718411573899296768

Utilizing a Human–Computer Interaction Approach to Evaluate the Design of Current Pharmacogenomics Clinical Decision Support

Ejemplares similares